Evidence map›Paper›PMID 23354620›Full record

ArticleJournal of gastroenterology2013

Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients.

Tatsuo Inamine, Shingo Higa, Fumie Noguchi, Shinji Kondo, Katsuhisa Omagari, Hiroshi Yatsuhashi, Kazuhiro Tsukamoto, Minoru Nakamura

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review: Pathogenesis of cholestatic liver diseases.World journal of hepatology · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Review
  11. Predictors of liver failure in primary biliary cirrhosis.Upsala journal of medical sciences · 2015
    Article
  12. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.Liver international : official journal of the International Association for the Study of the Liver · 2015
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Tatsuo InamineDepartment of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Sciences, 1-14 Bunkyo-machi, Nagasaki, 852-8521, Japan.
Shingo Higa
Fumie Noguchi
Shinji Kondo
Katsuhisa Omagari
Hiroshi Yatsuhashi
Kazuhiro Tsukamoto
Minoru Nakamura
Nagasaki University · JPInoue Hospital · JPNagasaki Medical Center · JPUniversity of Nagasaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with primary biliary cirrhosis (PBC) exhibit a variety of clinical manifestations and patterns of disease progression. The aim of this study was to identify genetic determinants of PBC progression.

methodsA total of 52 tag single nucleotide polymorphisms (SNPs) of 11 candidate genes involved in regulating bile acid synthesis were analyzed by polymerase chain reaction (PCR)-restriction fragment length polymorphism, -high resolution melting curve analysis, or -direct DNA sequencing in 315 Japanese patients with PBC.

resultsIn this study, four tag SNPs of CYP7A1 (rs1457043, rs8192870, rs3808607, and rs3824260), two tag SNPs of HNF4A (rs6017340 and 6031587), and one SNP of PPARGC1A (rs8192678) showed a significant association with PBC progression. In addition, a dual luciferase assay revealed that the polymorphism of rs3808607 in CYP7A1 altered the expression of CYP7A1 in HepG2. Specifically, the CYP7A1 promoter carrying the risk G allele for PBC progression induced higher expression of CYP7A1 under both the normal and cholestatic conditions in vitro as compared to another promoter carrying the non-risk T allele.

conclusionThese results suggested that the genetic variants of CYP7A1 and its transcriptional activators (HNF4A and PPARGC1A) may activate bile acid synthesis, resulting in the accumulation of bile acids in hepatocytes and eventually leading to the predisposition to PBC progression. Thus, the regulation of CYP7A1 expression may represent an attractive therapeutic target for cholestatic liver diseases including PBC.

Indexed as

Polymorphism, Single NucleotideAgedBile Acids and SaltsCholesterol 7-alpha-HydroxylaseCohort StudiesDisease ProgressionFemaleGenetic Predisposition to DiseaseGenotypeHepatocyte Nuclear Factor 4HumansJapanLiver Cirrhosis, BiliaryMaleMiddle AgedPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaBile Acids and SaltsCholesterol 7-alpha-HydroxylaseCYP7A1 protein, humanHepatocyte Nuclear Factor 4HNF4A protein, humanPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanTranscription Factors

Identifiers

PMID23354620
OpenAlexW2049662574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.